Altimmune, Inc.
ALT
$2.91
-$0.02-0.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.93% | 7.33% | 18.94% | 13.42% | 2.72% |
| Total Depreciation and Amortization | -33.75% | -52.94% | -62.70% | 147.78% | 119.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.64% | 23.99% | -50.59% | -57.86% | -52.97% |
| Change in Net Operating Assets | 862.64% | 65.99% | 121.48% | -150.29% | 49.17% |
| Cash from Operations | 10.82% | 15.42% | 15.06% | -14.11% | -10.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,271.53% | -366.65% | 20.62% | 336.98% | 115.43% |
| Cash from Investing | -2,272.06% | -366.68% | 20.60% | 336.96% | 115.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 380.29% | 1,497.77% | 66.45% | 12.42% | -47.81% |
| Repurchase of Common Stock | 21.77% | 16.59% | 22.49% | 21.86% | 18.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,121.49% | -- | -- | -- | -179.61% |
| Cash from Financing | 465.45% | 1,959.36% | 86.76% | 32.42% | -48.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 262.34% | 106.96% | 153.74% | 378.56% | -16.21% |